ProPhase Labs Inc PRPH

NAS: PRPH | ISIN: US74345W1080 26/04/2024

4,710 USD (-4,85%)

(-4,85%) 26/04/2024

Grafiek ProPhase Labs Inc

Grafiek ProPhase Labs Inc

1 dag1d -4,85%
1 week1w -3,88%
1 maand1m -27,20%
3 maanden3m -1,46%
6 maanden6m 4,20%
1 jaar1j -37,20%
5 jaar5j 56,74%

ProPhase Labs Inc in het nieuws

Toon enkel gratis nieuws

27 april 2023 · COMSovereign Names Bill White, CFE as New Independent Director and Chair of Audit Committee · Persbericht

15 maart 2021 · ProPhase Labs to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Wednesday, March 31, 2021 at 4:30 p.m. Eastern Time · Persbericht

9 februari 2021 · ProPhase Labs Begins Advanced, Saliva-based Viral PCR Multiplex-Testing for COVID-19, Influenza A & B, and Other Viruses After FDA Confirmation of Two Emergency Use Authorizations · Persbericht

1 februari 2021 · ProPhase Labs Exceeding Initial Goals as Covid-19 Lab Testing Business Ramps up · Persbericht

29 januari 2021 · ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York · Persbericht

21 januari 2021 · ProPhase Labs, Inc. Announces Closing of Public Offering · Persbericht

19 januari 2021 · ProPhase Labs Announces Pricing of Public Offering of Common Stock · Persbericht

15 januari 2021 · ProPhase Labs Announces Proposed Public Offering of Common Stock · Persbericht

5 januari 2021 · ProPhase Labs Announces $5.5 Million Registered Direct Offering of Common Stock and Warrants · Persbericht

Profiel ProPhase Labs Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Huishoudelijke/Persoonlijke Verzorging

Niet-duurzame consumptiegoederen

Werknemers: 53

Aandelen ProPhase Labs Inc

Beurswaarde: 84,99 miljoen USD

Effecten: 18,05 miljoen

Beta: -0,19

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe